Latest

SARS_CoV_2

This shows the outline of a head and a question mark

Featured Neurology Neuroscience Open Neuroscience Articles

·April 1, 2022·3 min read

COVID-19’s Lingering Impacts on the Brain

Study reveals, in detail, how COVID-19 infection affects the central nervous system, including inducing brain injury and inflammation consistent with reduced cerebral blood flow.

Featured Neuroscience

·March 23, 2022·6 min read

Oral Drug Prevents Death From COVID-19 in Old Mice by Reversing Immune Aging

BGE-175, an oral drug that reverses multiple aspects of immune aging effectively prevents death in mouse models of COVID-19.

This shows the covid-19 structure and a blood vessel

Featured Neurology Neuroscience

·July 18, 2021·4 min read

3D ‘Assembloid’ Shows How COVID-19 Infects Brain Cells

A newly created stem cell model demonstrates a potential route of entry of the COVID-19 virus, SARS_CoV_2, into the human brain.

Featured Neurology Neuroscience

·June 22, 2021·7 min read

Signs of Inflammation in Brains of People Who Died of COVID-19

Post-mortem studies of COVID-19 patients revealed significant signs of neuroinflammation and impaired brain circuits which researchers believe were caused by the disease. Researchers said the changes noticed in the brains of COVID patients were similar to the changes that occur in both Alzheimer's and Parkinson's disease.

This shows a man in a facemask surrounded by representations of covid-19

Featured Neurology Neuroscience

·June 11, 2021·4 min read

COVID-19 Linked to Alzheimer’s Disease-Like Cognitive Impairment

Combining artificial intelligence technology with data sets related to both Alzheimer's and COVID-19, researchers were able to identify a mechanism by which coronavirus can lead to Alzheimer's-like symptoms. The findings add to the growing body of evidence that COVID-19 infection can have lasting effects on brain function.

Featured Neuroscience Open Neuroscience Articles

·June 3, 2021·4 min read

The Dream Team: Drug Duo May Cure COVID-19

Two medications commonly used to treat inflammation and HIV infection have been repurposed in the fight against COVID-19. Researchers found combined cepharanthine/nelfinavir therapy can hasten the clearance of coronavirus infection from a person's lungs in as little as 4.9 days. Cepharanthine hindered the entry of SARS_CoV_2 into cells, preventing the virus from binding to a protein on the cell membrane it uses as a gateway. Nelfinavir prevented the virus from replicating inside cells by inhibiting a protein the virus relies on for replication.

This shows dying neurons and areas of brain tissue infected with SARS_CoV_2

Featured Neurology Neuroscience

·January 12, 2021·3 min read

SARS_CoV_2 Can Infect Neurons and Damage Brain Tissue

SARS_CoV_2, the virus responsible for COVID-19, can directly enter the nervous system. The virus can infect the brain, causing alterations in blood vessels and directly disrupt oxygen supply to the organ.

Featured Neurology Neuroscience

·January 5, 2021·5 min read

How COVID-19 Is Likely to Impact the Brain

Using over a century of data from other pandemics, and applying knowledge about the current COVID-19 infection, researchers predict the long term effects coronavirus will have on the brain and nervous system.

This shows a clock with the numbers falling off

Featured Neuroscience Psychology

·December 31, 2020·4 min read

A Year of Blursdays: How Coronavirus Distorted Our Sense of Time in 2020

Many people reported they felt like time was passing differently during the initial COVID-19 lockdowns. Researchers explore how the pandemic has contributed to the feeling of time distortion.

Featured Neurology Neuroscience

·December 30, 2020·5 min read

Study Uncovers Blood Vessel Damage & Inflammation in COVID-19 Patients’ Brains but No Infection

Researchers found hallmarks of damage caused by thinning and leaky blood vessels in brain samples of people after contracting COVID-19, but saw no evidence of SARS_CoV_2 in the tissue samples. Findings suggest the damage was not caused by a direct viral attack on the brain, but by the body's immune response to the infection.

This shows how the antibody works to combat covid-19

Featured Genetics Neuroscience Open Neuroscience Articles

·December 22, 2020·5 min read

Neuroscientists Isolate Promising Mini Antibodies Against COVID-19 From a Llama

Researchers have isolated a set of antibodies from a llama which show promise for the treatment of COVID-19. The NIH-CoVnB-112 nanoantibody bound to ACE2 receptors up to ten times stronger than other lab-produced antibodies. The nanoantibody stuck directly to the ACE2 receptor binding portion of the SARS_CoV-2 spike protein. The protein could be effective in preventing coronavirus infection.